Dubbed the “world’s smallest heart pump,” the Impella pump reduces the workload of the patient’s heart muscle during the stenting procedure. It is the only FDA-approved, non-surgical heart pump.
“It assists the pumping function of the heart to efficiently deliver blood and oxygen to the entire body and ensures blood flow is maintained to critical organs,” said Simil Gala, MD, interventional cardiologist at Prevea. “This allows us to more safely perform the stenting procedure and better ensure a successful outcome for these patients.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
